From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.
- DOI
- 10.1158/0008-5472.can-03-4063
- Published
- 2004 Jun 15
- Container
- Cancer research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-03-4063,
title = {From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.},
author = {Zhu J and Huang JW and Tseng PH and Yang YT and Fowble J and Shiau CW and Shaw YJ and Kulp SK and Chen CS},
year = {2004},
journal = {Cancer research},
doi = {10.1158/0008-5472.can-03-4063},
url = {https://doi.org/10.1158/0008-5472.can-03-4063}
}RIS
TY - JOUR TI - From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. AU - Zhu J AU - Huang JW AU - Tseng PH AU - Yang YT AU - Fowble J AU - Shiau CW AU - Shaw YJ AU - Kulp SK AU - Chen CS PY - 2004 JO - Cancer research DO - 10.1158/0008-5472.can-03-4063 UR - https://doi.org/10.1158/0008-5472.can-03-4063 ER -
APA
J, Z., JW, H., PH, T., YT, Y., J, F., CW, S., YJ, S., SK, K., & CS, C. (2004). From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.. Cancer research. https://doi.org/10.1158/0008-5472.can-03-4063
Source records
- pubmed · retrieved 2026-09-25T22:29:52.188Z